NFG
TBPH icon

Next Financial Group’s Theravance Biopharma TBPH Stock Holding History

Next Financial Group’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$4K – 1945
2017
Q2 		$4K Hold
100
– – ﹤0.01% 1627
2017
Q1 		$4K Sell
100
-150
-60% -$4.79K ﹤0.01% 1582
2016
Q4 		$8K Hold
250
– – ﹤0.01% 1768
2016
Q3 		$9K Buy
250
+150
+150% +$4.18K ﹤0.01% 1714
2016
Q2 		$2K Sell
100
-814
-89% -$17.6K ﹤0.01% 1611
2016
Q1 		$17K Buy
914
+272
+42% +$4.45K 0.01% 1006
2015
Q4 		$10K Buy
642
+50
+8% +$793 ﹤0.01% 1181
2015
Q3 		$6K Hold
592
– – ﹤0.01% 1380
2015
Q2 		$7K Hold
592
– – ﹤0.01% 1388
2015
Q1 		$10K Buy
592
+300
+103% +$5.5K ﹤0.01% 1248
2014
Q4 		$4K Sell
292
-28
-9% -$488 ﹤0.01% 1599
2014
Q3 		$7K Buy
+320
New +$9.28K ﹤0.01% 1945

Other funds holding TBPH

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Next Financial Group's TBPH Position: Q3 2017 in Review

Next Financial Group sold out of Theravance Biopharma (TBPH) in Q3 2017, closing a stake of 100 shares — an estimated $4K sold.

Next Financial Group first reported a position in TBPH in Q3 2014 and held it in 12 quarters. The position peaked at $17K in Q1 2016. 84 funds tracked by Wall St. Rank hold TBPH as of Q3 2017.

  • Next Financial Group reported no remaining Theravance Biopharma position as of Q3 2017 after selling out during the quarter.
  • Next Financial Group sold 100 Theravance Biopharma shares in Q3 2017, an estimated $4K.
  • Next Financial Group first reported a position in Theravance Biopharma in Q3 2014 and held it in 12 quarters.
  • Next Financial Group's Theravance Biopharma position peaked at $17K in Q1 2016.
  • 84 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2017.

Based on Next Financial Group's 13F filing for Q3 2017, filed 8 Nov 2017.